Disease-causing variants in SCN1A are identified in up to 80% of individuals with clinical Dravet syndrome, and hundreds of individuals are diagnosed every year. Here, SCN1A is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.